Back
Dr Reddy's Laboratories 10K Form
Sell
45
RDY
Dr Reddy's Laboratories
Last Price:
14.59
Seasonality Move:
2.47%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive RDY News And Ratings
See the #1 stock for the next 7 days that we like better than RDY
RDY Financial Statistics
Sales & Book Value
| Annual Sales: | $3.37B |
|---|---|
| Cash Flow: | $24.84M |
| Price / Cash Flow: | 48.07 |
| Annual Sales: | $4.24 |
| Price / Book: | 3.45 |
Profitability
| EPS (TTM): | 0.80250 |
|---|---|
| Net Income (TTM): | $668.83M |
| Gross Margin: | $1.98B |
| Return on Equity: | 20.73% |
| Return on Assets: | 14.97% |
Dr Reddy's Laboratories Earnings Forecast
Key Dr Reddy's Laboratories Financial Ratios
- The Gross Profit Margin over the past 24 years for RDY is 58.61%.
- The Selling, General & Administrative Expenses for RDY have been equal to 27.65% of Gross Profit Margin.
- The Research & Development expenses have been 8.19% of Revenue.
- The Interest Expense is 3.07% of Operating Income.
- The Net Earning history of RDY is 19.95% of Total Revenues.
- Per Share Earnings over the last 24 years have been positive in 14 years.
Dr Reddy's Laboratories Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NYSE |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | RDY |
| CUSIP: | 256135 |
| Website: | drreddys.com |
Debt
| Debt-to-Equity Ratio: | 0.09 |
|---|---|
| Current Ratio: | 2.55 |
| Quick Ratio: | 1.66 |
Price-to-Earnings
| Trailing P/E Ratio: | 18.1 |
|---|---|
| Forward P/E Ratio: | 18.32 |
RDY Technical Analysis vs Fundamental Analysis
Sell
45
Dr Reddy's Laboratories (RDY)
is a Sell
Is Dr Reddy's Laboratories a Buy or a Sell?
-
Dr Reddy's Laboratories stock is rated a Sell
The current Dr Reddy's Laboratories [RDY] share price is $14.61. The Score for RDY is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.